Houston is one of only five WeWork Labs markets that can expect access to 3D printers as a part of a pilot program with two companies. Courtesy of WeWork

WeWork has teamed up with two leading 3D printing companies to bring their technology into five WeWork Labs markets — including Houston's downtown location. The other locations tapped for the pilot program are London, San Francisco, New York, and Seattle.

Massachusetts-based Formlabs' Form 2 printer has over 20 different material resins WeWork Labs members can use to prototype and print products using desktop stereolithography.

"Formlabs was founded eight years ago on the basis of empowering anyone to make anything," says Max Lobovsky, CEO and co-founder of Formlabs in a release. "Today, our customers have printed more than 40 million parts, they vary from early stage entrepreneurs changing the status quo and developing new applications to Fortune 500s experimenting with new business models or production methods."

The other company involved in the program is Seattle-based Glowforge, which created a 3D laser printer. Glowforge Plus uses subtractive laser technology to cut and sculpt projects from materials like wood, leather, acrylic, stone — and even stickers. The company, which was founded in 2014, has had over three million prints on its devices — everything from jewelry and clothing to machinery.

"We are thrilled to partner with WeWork Labs to provide their community of entrepreneurs and startups alike access to the tools that will help them create corporate giveaways, new product prototypes, and full production runs — everything to take their dreams from idea to creation," says Dan Shapiro, CEO of Glowforge, in the release.

The printers will be revealed at various launch events celebrating the National Week of Making, which begins June 21 and goes through June 27. Houston's launch event will be on June 28, but the specifics have not yet been finalized.

"We see WeWork Labs as a platform for creators, innovators and makers alike, and believe partnering with Glowforge and Formlabs will give our members even more of an opportunity to take their ideas, and bring them to life," says Katie Perkins, creative director at WeWork Labs, in the release. "We are incredibly excited to welcome two leading brands and their products into our community, giving creators access to the tools they need and inspiring new creators to be makers themselves."

Houston's WeWork Labs program launched in March in the WeWork Jones Building at 708 Main St. and includes a partnership with local digital startup resource, Alice. The WeWork Labs program started a little over a year ago and is already in over 30 markets worldwide.

"As the fourth largest city, Houston is in a unique position to launch high-impact startups," says Houston Labs Manager Carlos Estrada, in a previous release. "We see WeWork Labs in Houston as a tremendous platform for innovation, as our founder-focused approach to supporting early-stage startups will nurture and accelerate the work of entrepreneurs to scale their solutions to today's biggest challenges."

Form 2

Courtesy of WeWork

Using 20 types of resin materials, Formlabs' Form 2 can create parts or prototypes.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

European spacecraft developer expands to Houston with U.S. business, new lab

houston hq

European aerospace manufacturer The Exploration Company has established its first U.S. entity and named Space City as its headquarters.

The company announced earlier this month that it has launched TEC Federal to support U.S. government customers and agencies, and to scale The Exploration Company's engineering operations in the country.

Mark Kirasich serves as president of TEC Federal. Kirasich most recently served as the senior director of human spaceflight at Blue Origin after a nearly 40-year career at NASA.

The Exploration Company is developing the reusable Nyx space vehicle. Nyx is designed to take off from any heavy launcher in the world. It will then dock at space stations, retrieve up to 3,000 kilograms of cargo, splash down and return the cargo to Earth. The company aims to make Nyx fully reusable for up to 10 missions, making it a more affordable and sustainable option for aerospace missions.

The Exploration Company completed a successful drop test of the spacecraft in May in the Mojave Desert. The company says Nyx is slated to perform its first flight demonstration in 2028.

In addition to launching the Houston business, The Exploration Company also opened its new Rapid Innovation Lab near Houston's NASA Johnson Space Center on Space Park Drive.

The Exploration Company opened its Rapid Innovation Lab earlier this month. Photo via LinkedIn

The Rapid Innovation Lab features a full-scale mockup of the future Nyx crew capsule as well as ongoing development and testing of the Nyx cargo capsule, according to the company.

The Exploration Company says the new lab will allow its engineers, designers, and operators to prototype and test crew interfaces. It will also support partnerships with NASA personnel and astronauts.

“Houston gives us direct access to the people and expertise that have built and operated human spaceflight systems for decades. We’re excited to invest and expand around that— engineers, operators, and astronauts working together and moving quickly towards building a crew capsule.” Hélène Huby, founder and CEO of The Exploration Company, said in a blog post.

According to The Houston Chronicle, The Exploration Company has about 30 employees in the Houston area.

The company was founded in 2021 by Huby, a French rocket scientist, and has raised more than $350 million in venture capital. It operates out of Germany, France, Luxembourg, Spain and Italy, with offices in the U.S. and the United Arab Emirates. It is also developing a reusable, high-thrust rocket engine known as Storm.

UH lands $4M NIH grant to study early signs of autoimmune disease

NIH funding

The University of Houston recently received a $4 million National Institutes of Health grant to support a 10-year longitudinal study to identify the earliest biological markers of autoimmune disease.

Led by Chandra Mohan, the Hugh Roy and Lillie Cranz Cullen Endowed Professor of Biomedical Engineering, the study aims to examine what causes Systemic Autoimmune Rheumatic Diseases (SARDs) and to identify targets for future treatments. The study will be carried out in collaboration with Dr. Karen Costenbader at Harvard Medical School, Boston.

SARDs include conditions like rheumatoid arthritis, systemic lupus erythematosus, Sjögren’s syndrome and systemic sclerosis—all are considered chronic diseases currently without a cure. Autoimmune diseases affect over 30 million people globally, according to UH.

SARDs occur when the body’s immune system attacks healthy, non-threatening tissues and organs. According to UH, in these diseases, the body often attacks nuclear antigens, creating anti-nuclear autoantibodies, which can be early detection signs for SARDs in more than 50 percent of patients, Mohan says.

Researchers will study blood samples and environmental exposure over the 10 years to better understand anti-nuclear autoantibodies.

“Collectively, these studies will help identify the genetic, environmental and cellular factors that are operative at the two steps of SARD development, namely the emergence of anti-nuclear autoantibodies and disease onset,” Mohan said in a news release. “ More importantly, these studies will highlight functional molecular pathways and mechanisms that may be operative at each step."

Mohan predicts that looking at SARDs’ shared characteristics, rather than each disease individually, could help identify more treatment methods.

“Individual SARDs have been examined in silos without an attempt to discern shared underlying features at the molecular level,” he added in the release. “Current understanding of the initial (and likely shared) origins of SARDs is only rudimentary but urgently needed to develop means for prevention and treatment.”

Earlier this year, UH also received an $11 million NIH grant to conduct a first-of-its-kind study of early language development in children ages 18 to 24 months. Read more here.